Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

Franklin Genomic Advancements ETF

HELX

Current price

30.8 USD -0.43 USD (-1.38%)

Company –

ISIN US35473P5200

Category Healthcare

Exchange BATS

Capitalization 11 030 276 USD

Yield for 12 month +17.29 %

10Y

15Y

HELX

21.11.2021 - 28.11.2021

Franklin Genomic Advancements ETF, a constituent of the ETF, is listed on the BATS. Its market capitalization stands at 11 030 276 USD. Over the past year, it has generated a yield of +17.29 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.5 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Analytics

Total Assets

11 030 276 USD

Net Expense Ratio

0.5 %

Annual Holdings Turnover

32.63 %

Long 0.43%

Short -

Net Assets 0.43%

Long 87.23%

Short -

Net Assets 87.23%

Long 12.35%

Short -

Net Assets 12.35%

Long -

Short -

Net Assets -

Long -

Short -

Net Assets -

1y Volatility 20.70%

Returns YTD 3.48%

3y Volatility 22.91%

Returns 1Y 18.31%

3y ExpReturn 0.00%

Returns 3Y -14.80%

3y SharpRatio -0.89%

Returns 5Y 0.00%

Returns 10Y 0.00%

Dividend growth over 5 years

–

Continuous growth

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

27.09 USD 33.98 USD

50 Day MA 31.92 USD

200 Day MA 31.9 USD

	All time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

Franklin Genomic Advancements ETF